Literature DB >> 3883482

Mechanisms of bacterial superinfections in viral pneumonias.

G J Jakab.   

Abstract

Although it was once thought that bacterial infection was merely a function of the virulence of the microbe it is now known that other pathogens can alter host resistance. With respect to bacterial superinfection during viral pneumonias, three important factors must be considered; the role of the virus, the role of the bacterium, and the immune status of the host. The fact that no one bacterial species is responsible for all human cases of postinfluenzal bacterial pneumonia indicates that there is a general impairment of pulmonary antibacterial defenses brought about by the viral infection. The fact that the rate of intrapulmonary killing varies with different bacterial species indicates that the superinfecting organism can itself play a role in the dual disease process. Finally, it has been amply demonstrated that the resistance of the host is dependent on a variety of factors which include innate variables such as genetic endowment and a multitude of imponderable variables acquired through life experiences which can be considered under the general category of "host factors". All three factors interact and collectively impinge upon the resistance of the host. Lastly, as influenza virus infections occur most frequently in epidemic outbreaks, the relationship between influenza virus and secondary bacterial infections is the classic example. However, there is growing evidence that an association exists between other virus groups and bacterial pathogens in respiratory tract infections. Adenovirus, parainfluenza virus, and rhinovirus are among the agents that appear to pave the way for bacterial pneumonias. Mycoplasma pneumoniae, once considered to be a virus and the cause of primary atypical pneumonia, may also render the respiratory tract susceptible to bacterial invasion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883482

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  9 in total

1.  The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart.

Authors:  M Khanna; J Fan; K Pehler-Harrington; C Waters; P Douglass; J Stallock; S Kehl; K J Henrickson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Pulmonary antibacterial defenses during mild and severe influenza virus infection.

Authors:  C L Nickerson; G J Jakab
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 3.  Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.

Authors:  Koenraad F van der Sluijs; Tom van der Poll; René Lutter; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

Review 4.  Immune dysfunction and bacterial coinfections following influenza.

Authors:  Dennis W Metzger; Keer Sun
Journal:  J Immunol       Date:  2013-09-01       Impact factor: 5.422

5.  In Vitro Antiviral Activity of Sakuranetin against Human Rhinovirus 3.

Authors:  Hwa-Jung Choi
Journal:  Osong Public Health Res Perspect       Date:  2017-12-31

6.  Rhinovirus C targets ciliated airway epithelial cells.

Authors:  Theodor F Griggs; Yury A Bochkov; Sarmila Basnet; Thomas R Pasic; Rebecca A Brockman-Schneider; Ann C Palmenberg; James E Gern
Journal:  Respir Res       Date:  2017-05-04

Review 7.  Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness.

Authors:  John F Brundage
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

Review 8.  The role of respiratory epithelium in host defence against influenza virus infection.

Authors:  Laura Denney; Ling-Pei Ho
Journal:  Biomed J       Date:  2018-09-10       Impact factor: 4.910

Review 9.  Developing animal models for polymicrobial diseases.

Authors:  Lauren O Bakaletz
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.